1
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Breast
1
Conditions
Neoplasms
1
Liver Neoplasms
1
Breast Neoplasm Malignant Female
1
Interventions
Cisplatin
3202
Cyclophosphamide
3195
Carboplatin
2977
Radiotherapy
2790
Paclitaxel
2718
Gemcitabine
2572
pembrolizumab
2385
Bevacizumab
2209
Docetaxel
2199
Fluorouracil
1851
Capecitabine
1833
Oxaliplatin
1742
Dexamethasone
1605
Nivolumab
1581
Doxorubicin
1501
Rituximab
1488
Magnetic Resonance Spectroscopy
1387
Etoposide
1346
Irinotecan
1248
Leucovorin
1226
Drug Therapy
1205
Cytarabine
1130
Pemetrexed
1076
fludarabine
1063
Specimen Handling
1017
Vincristine
964
Cetuximab
945
Trastuzumab
945
Prednisone
942
Lenalidomide
937
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Immunophenotyping
×
Clear all
NCT04198727
2026-06-02
DPDMAX
Centre Antoine Lacassagne
Phase 2
Active not recruiting
155 enrolled
NCT06146127
2023-11-24
PREMED-CHC
Inserm U955
Unknown
300 enrolled